Literature DB >> 29323557

Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.

Maria Rita Polo Gascón1, José Ernesto Vidal2, Yolanda Marques Mazzaro1, Jerusa Smid2, Rosa Maria Nascimento Marcusso2, Claudio Garcia Capitão2, Elizeu Macedo Coutinho3, Glaucia Rosana Guerra Benute1, Mara Cristina Souza De Lucia1, Augusto César Penalva de Oliveira4.   

Abstract

HIV-associated neurocognitive disorders (HAND) remain frequent even among individuals receiving combined antiretroviral therapy (cART). In addition, HAND may adversely affect the quality of life and adherence to cART. There is scarce epidemiological information about HAND in Latin America. This cross-sectional study recruited HIV-infected patients from a tertiary teaching institution in São Paulo, Brazil, between May 2013 and February 2015. The patients were adults with at least 4 years of education and patients with current neurological or psychiatric diseases were excluded. HAND remain frequent even among individuals receiving cART, use of psychoactive substance, or inability to understand the content for neuropsychological evaluation. We used standardized tools to evaluate depression, use of psychoactive substances, and daily life activities, and we performed a comprehensive neuropsychological examination. HAND was classified using the Frascati criteria. Prevalence of HAND was estimated, and an associated variable of symptomatic HAND was identified by logistic regression. Four-hundred twelve HIV-infected patients were included [male: 281 (68%), mean age of 45.3 years]. Most of them [n = 340 (83.7%)] had an undetectable viral load. The prevalence of HAND was 73.6% (n = 303): 210 (50.9%) had asymptomatic neurocognitive involvement (ANI), 67 (16.2%) had mild neurocognitive disorder (MND), and 26 (6.3%) had HIV-associated dementia (HAD). The univariate logistic regression analysis showed that female gender, age older than 50 years, <11 years of schooling, CD4 count below 200 cells/mm3, presence of previous illnesses (e.g., diabetes, hypertension), opportunistic disease history, and a Beck Depression Inventory (BDI) score between 13 and 19 points were factors associated with symptomatic HAND (MND and HAD). However, a BDI score between 13 and 19 points was the single independent variable associated with symptomatic HAND. HAND was highly prevalent in São Paulo, Brazil, and ANI was the more frequent category of HAND. However, 22.5% of participants had symptomatic HAND. This finding constitutes a challenge in clinical practice. A BDI score between 13 and 19 points was the single independent variable associated with symptomatic HAND.

Entities:  

Keywords:  AIDS dementia complex; HIV; acquired immunodeficiency syndrome; central nervous system; neurocognitive disorders

Mesh:

Substances:

Year:  2018        PMID: 29323557     DOI: 10.1089/apc.2017.0202

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  10 in total

1.  Center for Epidemiological Studies-Depression Scale: Evaluation of a New Cutoff Score for Women Living with HIV.

Authors:  Anna Junkins; Andres Azuero; Corilyn Ott; Christina Jagielski; Karen Cropsey; Robert Savage; Christina Psaros; Steven Safren; Mirjam-Colette Kempf
Journal:  AIDS Patient Care STDS       Date:  2019-07-16       Impact factor: 5.078

Review 2.  Aging with HIV in Latin America and the Caribbean: a Systematic Review.

Authors:  Diego M Cabrera; Monica M Diaz; Alyssa Grimshaw; Justina Salvatierra; Patricia J Garcia; Evelyn Hsieh
Journal:  Curr HIV/AIDS Rep       Date:  2021-01-05       Impact factor: 5.071

3.  Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.

Authors:  Ned Sacktor; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; M Kate Grabowski; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

Review 4.  The Impact of Antiretroviral Therapy on Neurocognitive Outcomes Among People Living with HIV in Low- and Middle-Income Countries (LMICs): A Systematic Review.

Authors:  Henry Ukachukwu Michael; Sasha Naidoo; Kofi Boamah Mensah; Suvira Ramlall; Frasia Oosthuizen
Journal:  AIDS Behav       Date:  2021-02

Review 5.  Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms.

Authors:  Leah H Rubin; Gretchen N Neigh; Erin E Sundermann; Yanxun Xu; Eileen P Scully; Pauline M Maki
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

6.  Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study.

Authors:  Minale Tareke; Tilahun Belete; Temesgen Ergetie; Meseret Tadesse; Melak Menberu; Asmamaw Ketemaw
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 5.435

7.  Low Quality of Life, Falls, and Pre-Frailty are Associated with Depressive Symptoms in Virologically Suppressed PLWHIV in Salvador, Brazil.

Authors:  Rafael Antonius Araujo; Sávio Amaral; Arthur Tolentino; Diana Zeballos; Iris Montaño; Lucca S Souza; Liliane Lins-Kusterer; Carlos Brites
Journal:  AIDS Behav       Date:  2021-07-26

8.  Sex Differences in the Patterns and Predictors of Cognitive Function in HIV.

Authors:  Leah H Rubin; Erin E Sundermann; Raha Dastgheyb; Alison S Buchholz; Elizabeth Pasipanodya; Robert K Heaton; Igor Grant; Ronald Ellis; David J Moore
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.086

9.  Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru.

Authors:  Monica M Diaz; Marcela Gil Zacarías; Patricia Sotolongo; María F Sanes; Donald J Franklin; María J Marquine; Mariana Cherner; Cesar Cárcamo; Ronald J Ellis; Serggio Lanata; Patricia J García
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.086

Review 10.  Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research.

Authors:  Thomas A Premeaux; Sonia Mediouni; Ana Leda; Robert L Furler; Susana T Valente; Howard A Fine; Douglas F Nixon; Lishomwa C Ndhlovu
Journal:  mBio       Date:  2021-07-13       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.